Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome.

Our vision
We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure.

Our values
Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic solutions based on the human microbiome through excellence in its processes, empathising with chronic patients for whom no curative treatments are available, always from the perspective of networking with all stakeholders in the sector.

Biotechnology

Health Care

Therapeutics

Mikrobiomik

Mikrobiomik's headquarters in Derio, Spain

Description

People (5)

Jobs (0)

Other offices